Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Cadrenal Therapeutics Inc increased its cash reserves by 25,682.45%, or 8.37m. Cash Flow from Financing totalled 11.90m or -- of revenues. In addition the company used 3.53m for operations while cash used for investing totalled 3.25k.
Cash flow per share | -5.89 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.74 |
---|---|
Tangible book value per share | 3.74 |
More ▼
Balance sheet in USDView more
Current ratio | 3.72 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼